Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Oriental Culture Holding LTD Ordinary Shares (OCG)

http://www.ocgroup.hk

Oriental Culture Holding Ltd is an online provider of collectibles and artwork e-commerce services. The company also offers online and offline integrated marketing, storage, and technical maintenance service to customers in China and Hong Kong. It operates through one segment namely, e-commerce of artwork trading. It generates revenue through listing service fees, transaction fees, and other revenues collected from traders.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/15/2020

Market Cap

5,219,100

Shares Outstanding

4,250,000

Weighted SO

4,245,398

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

HOUR --.--%

JWEL --.--%

QRTEB --.--%

EMCMF --.--%

YJ --.--%

PIK --.--%

SECO --.--%

JFBR --.--%

Beta

1.6030

Last Div

0.0000

Range

0.85-3.94

Chg

-0.0578

Avg Vol

11845

Mkt Cap

5219100

Exch

NASDAQ

Country

HK

Phone

852 2110 3909

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

3.3031

EV Multiple

3.3432

P/FV

0.1071

Div Yield %

0.0000

P/E

-1.3551

PEG

-0.0485

Payout

0.0000

Current Ratio

12.2983

Quick Ratio

12.4106

Cash Ratio

5.7394

DSO

79.9538

DIO

-311.4470

Op Cycle

-231.4932

DPO

2334.6690

CCC

-2566.1621

Gross Margin

0.7433

Op Margin

-2.7438

Pretax Margin

-2.2680

Net Margin

-2.2774

Eff Tax Rate

-0.0041

ROA

-0.0740

ROE

-0.0782

ROCE

-0.0952

NI/EBT

1.0041

EBT/EBIT

0.8266

EBIT/Rev

-2.7438

Debt Ratio

0.0002

D/E

0.0003

LT Debt/Cap

0.0000

Total Debt/Cap

0.0003

Int Coverage

0.0000

CF/Debt

0.0000

Equity Multi

1.0676

Rec Turnover

4.5651

Pay Turnover

0.1563

Inv Turnover

-1.1719

FA Turnover

0.1721

Asset Turnover

0.0325

OCF/Share

0.0000

FCF/Share

0.0000

Cash/Share

4.9027

OCF/Sales

0.0000

FCF/OCF

0.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.1071

P/B

0.1071

P/S

3.3031

P/E

-1.3551

P/FCF

0.0000

P/OCF

0.0000

P/CF

0.0000

PEG

-0.0485

P/S

3.3031

EV Multiple

3.3432

P/FV

0.1071

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 16, 07:30 Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board MarketWatch Jan 03, 10:10 Nvidia and other stocks "approaching the trough of disillusionment" over GenAI MarketWatch Jan 03, 08:55 Nvidia and other stocks "approaching the trough of disillusionment" over GenAI MarketWatch Jan 03, 06:51 Nvidia and other stocks "approaching the trough of disillusionment" over GenAI GlobeNewswire Inc. Dec 21, 06:30 Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design GlobeNewswire Inc. Dec 19, 07:30 Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations GlobeNewswire Inc. Dec 13, 07:30 Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410—Modifier Gene Therapy—for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration GlobeNewswire Inc. Nov 29, 07:30 Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference GlobeNewswire Inc. Nov 17, 16:30 Oriental Culture Holding LTD Announces First Half Year of 2023 Unaudited Financial Results GlobeNewswire Inc. Nov 10, 07:30 Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST—Modifier Gene Therapy—for Stargardt Disease The Motley Fool Nov 09, 11:45 Ocugen (OCGN) Q3 2023 Earnings Call Transcript GlobeNewswire Inc. Nov 07, 07:45 Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic Development Summit GlobeNewswire Inc. Nov 02, 08:30 Oriental Culture Holding LTD. Regains Compliance with Nasdaq’s Minimum Bid Price Rule GlobeNewswire Inc. Nov 02, 07:30 Ocugen to Host Conference Call on Thursday, November 9 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2023 Financial Results

Revenue Product Segmentation